Form D · Other Health Care
Innovoyce LLC
Boston, MA · CIK 0001945041
Offering snapshot reported Oct 11, 2022 · SEC filing
- Reported sold
- $9.87M Offering amount: $14.9M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 28, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 11, 2022 | Initial | $9,868,439 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-461368
Units of Limited Liability Company Interests
Source: Form D, filed Oct 11, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tome Andrade | Director |
| Michael Davin | Executive, Promoter |
| Robert Hillman | Director |
| Steven Zeitels | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
25 Dorchester Avenue, #52318
Boston, MA, 02205
Boston, MA, 02205